August 29, 2018

Media

Media & events

news

Lyndra Therapeutics Welcomes Dr. Patricia Hurter as Chief Executive Officer

June 3, 2019
Lyndra Therapeutics Welcomes Dr. Patricia Hurter as Chief Executive Officer Addition to management team strengthens Lyndra’s development capabilities WATERTOWN, Mass.,...
Read More
1 2 3 11

publications

  • A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease
    A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease
1 2 3 5
200px-Elsevier.svg
200px-Elsevier.svg
A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease

Rosemary Kanasty, Susan Low, Nupura Bhise, JungYanga, ErickPeeke, MarleneSchwarz, JimWright, BennettCarter, SaumyaMoorthy, TylerGrant, BenDeBenedictis, MeganBishoff, CraigSimsesAndrew M.Bellinger

URL : View Project

events

Lyndra Presents @ BIO International

Join us on Thursday, June 5th,  at 5pm when Andrew Bellinger, our CSO, presents our 2019 Company Update at BIO International, Philadelphia Convention Center, Theater 4

2019 BIO International